Prolog Lonza Consumer Fund


We formed the Prolog Lonza Consumer Fund in partnership with Lonza Specialty Ingredients, a world leader in microbial control solutions. The fund invests in startups that promote effective hygiene everywhere, from hospitals and public areas to workplaces and homes. We back passionate founders throughout North America who create transformative approaches, technologies, and business models.


Target Sectors

Hygiene | Infection Control | Home & Body Care


CleanSlate UV Proves 99.995% Effective Against SARS-CoV-2 on Cell Phones and Other Mobile Devices
November 10, 2020 CleanSlate UV
Kinnos among eight finalists selected to fight coronavirus on NYC public transit
October 28, 2020 Kinnos
As part of its expanding focus on health and wellness, Costco brought the indie plant-based skin-care brand BioClarity to its e-commerce site this June
October 28, 2020 Glossy on bioClarity
This med student company’s product could make hospitals safer
October 6, 2020 AMA on Kinnos
Toronto Pearson Enhances Commitment to Healthy Airport by Partnering with CleanSlate UV
October 6, 2020 CleanSlate UV
Hudson’s Bay Enhances Customer Health and Safety with Innovative Technology in Stores
September 3, 2020 CleanSlate UV
bioClarity SunShady SPF 30 Wins SELF Magazine Healthy Beauty Award
July 8, 2020 SELF Magazine on bioClarity
Kinnos selected as One of Med Tech Outlook’s Top Infection Control Solution Providers
July 8, 2020 Medical Tech Outlook on Kinnos
We’ve been focusing on hygiene and microbial control solutions for the past two years, not just the last two months
July 1, 2020 Prolog in Venture Capital Journal
Kinnos Adds Industry and Public Health Veterans Amidst Growing Demand for Groundbreaking Infection Prevention Products
June 1, 2020 Kinnos
Why DTC beauty’s future may look more like its past
May 28, 2020 Glossy on bioClarity
Investing in Our First Line of Defense: Environmental Services Workers
May 9, 2020 Annals of Internal Medicine | Kevin Tyan, Kinnos